Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice

Maria Mercedes Santoro, Domenico Di Carlo, Daniele Armenia, Mauro Zaccarelli, Carmela Pinnetti, Manuela Colafigli, Francesca Prati, Andrea Boschi, Anna Maria Degli Antoni, Filippo Lagi, Laura Sighinolfi, Cristina Gervasoni, Massimo Andreoni, Andrea Antinori, Mussini Cristina, Carlo Federico Perno, Vanni Borghi, Gaetana Sterrantino

Research output: Contribution to journalArticle

Original languageEnglish
JournalAntiviral Therapy
DOIs
Publication statusPublished - Nov 22 2017

Cite this

Santoro, M. M., Di Carlo, D., Armenia, D., Zaccarelli, M., Pinnetti, C., Colafigli, M., Prati, F., Boschi, A., Degli Antoni, A. M., Lagi, F., Sighinolfi, L., Gervasoni, C., Andreoni, M., Antinori, A., Cristina, M., Perno, C. F., Borghi, V., & Sterrantino, G. (2017). Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice. Antiviral Therapy. https://doi.org/10.3851/IMP3197